Pulmonary atresia: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com, -kfeeney@perfuse.org +kfeeney@elon.edu))
 
(25 intermediate revisions by 5 users not shown)
Line 15: Line 15:
}}
}}
{{Pulmonary atresia}}
{{Pulmonary atresia}}
{{CMG}}; {{AE}} : {{mwaq}}


{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], {{CZ}}; '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu]
{{SK}}  


==[[Pulmonary atresia overview|Overview]]==
==[[Xyz overview|Overview]]==


==[[Pulmonary atresia pathophysiology|Pathophysiology]]==
==[[Xyz historical perspective|Historical Perspective]]==
 
==[[Xyz classification|Classification]]==
 
==[[Xyz pathophysiology|Pathophysiology]]==
 
==[[Xyz causes|Causes]]==
 
==[[Xyz differential diagnosis|Differentiating Xyz from other Diseases]]==
 
==[[Xyz epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Xyz risk factors|Risk Factors]]==
 
==[[Xyz screening|Screening]]==
 
==Diagnosis==
[[Xyz diagnostic study of choice|Diagnostic study of choice]] | [[Xyz history and symptoms|History and Symptoms]] | [[Xyz physical examination|Physical Examination]] | [[Xyz laboratory findings|Laboratory Findings]] | [[Xyz electrocardiogram|Electrocardiogram]] | [[Xyz x ray|X-Ray Findings]] | [[Xyz echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Xyz CT scan|CT-Scan Findings]] | [[Xyz MRI|MRI Findings]] | [[Xyz other imaging findings|Other Imaging Findings]] | [[Xyz other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Xyz medical therapy|Medical Therapy]] | [[Xyz interventions|Interventions]] | [[Xyz surgery|Surgery]] | [[Xyz primary prevention|Primary Prevention]] | [[Xyz secondary prevention|Secondary Prevention]] | [[Xyz cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Xyz future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
[[Xyz case study one|Case #1]]
 
[[Category: (name of the system)]]


==[[Pulmonary atresia epidemiology and demographics|Epidemiology and demographics]]==
==[[Pulmonary atresia epidemiology and demographics|Epidemiology and demographics]]==
* While there is no difference in the incidence of Pulmonary atresia in male or female, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males than in females. <ref>https://www.uptodate.com/contents/pulmonary-atresia-with-intact-ventricular-septum-pa-ivs?search=pulmonary%20atresia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H172915282][https://emedicine.medscape.com/article/905119-overview#a5</ref>
1) The prevalence of Pulmonary Atresia with VSD is estimated to be around 0.07 per 1000 live breath. and 2.5-3.4 % among all congenital heart diseases.[https://emedicine.medscape.com/article/905119-overview#a5]
2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination.
- The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [https://www.uptodate.com/contents/pulmonary-atresia-with-intact-ventricular-septum-pa-ivs?search=pulmonary%20atresia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H172915282][https://emedicine.medscape.com/article/898167-overview#a6]


==[[Pulmonary atresia classifications|Classification]]==
==[[Pulmonary atresia classifications|Classification]]==
Line 29: Line 62:


==[[Pulmonary atresia causes|Causes]]==
==[[Pulmonary atresia causes|Causes]]==
==[[Pulmonary atresia differential diagnosis|Differentiating Pulmonary atresia from other Disorders]]==


==Diagnosis==
==Diagnosis==
Line 36: Line 67:


==Treatment==
==Treatment==
'''Medical:''' [[Pulmonary atresia medical therapy|Medical Therapy]]
'''Surgical:''' [[Pulmonary atresia surgery|Surgery]]
[[Pulmonary atresia primary prevention|Primary Prevention]] | [[Pulmonary atresia secondary prevention|Secondary Prevention]] | [[Pulmonary atresia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pulmonary atresia future or investigational therapies|Future or Investigational Therapies]]
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 21:08, 14 July 2020

For patient information click here

Pulmonary atresia
ICD-10 Q25.5
ICD-9 747.3
MedlinePlus 001091
MeSH C14.240.670

Pulmonary atresia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary atresia from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Labratory findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography or Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Pulmonary atresia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary atresia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary atresia

CDC on Pulmonary atresia

Pulmonary atresia in the news

Blogs on Pulmonary atresia

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pulmonary atresia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  : Muhammad Waqas, M.D.[2]

Synonyms and keywords:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Epidemiology and demographics

  • While there is no difference in the incidence of Pulmonary atresia in male or female, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males than in females. [1]

1) The prevalence of Pulmonary Atresia with VSD is estimated to be around 0.07 per 1000 live breath. and 2.5-3.4 % among all congenital heart diseases.[3]

2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination.

- The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [4][5]

Classification

Natural history, Complications, and Prognosis

Causes

Diagnosis

History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies

Treatment

References

External links


Template:WikiDoc Sources